| 1711 |
LUCIDASA |
DASATINIB 20 MG |
TABLET |
BOTTLE |
FOR THE TREAMENT OF NEWLY DIAGNOSED ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE, ADULT WITH CHRONIC, ACCELERATED, OR LYMPHOID BLAST PHASE PH+CML WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB, ADULT WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBASTIC LEUKEMIA WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY, PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH PH+CML IN CHRONIC PHASE |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 1299/25 |
25-FEB-2025 |
24-FEB-2030 |
View |
| 1712 |
LUCIDASA |
DASATINIB 50 MG |
TABLET |
BOTTLE |
FOR THE TREAMENT OF NEWLY DIAGNOSED ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE, ADULT WITH CHRONIC, ACCELERATED, OR LYMPHOID BLAST PHASE PH+CML WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB, ADULT WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBASTIC LEUKEMIA WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY, PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH PH+CML IN CHRONIC PHASE |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 1298/25 |
25-FEB-2025 |
24-FEB-2030 |
View |
| 1713 |
LUCIDASA |
DASATINIB 70 MG |
TABLET |
BOTTLE |
FOR THE TREAMENT OF NEWLY DIAGNOSED ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE, ADULT WITH CHRONIC, ACCELERATED, OR LYMPHOID BLAST PHASE PH+CML WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB, ADULT WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBASTIC LEUKEMIA WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY, PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH PH+CML IN CHRONIC PHASE |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 1300/25 |
25-FEB-2025 |
24-FEB-2030 |
View |
| 1714 |
LUCIDELA |
IDELALISIB 150 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA, IN COMBINATION WITH RITUXIMAB, IN PATIENTS FOR WHOM RITUXIMAB ALONE WOULD BE CONSIDERD APPROPRIATE THERAPY DUE TO OTHER CO-MORBIDITIES |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1312/25 |
07-APR-2025 |
06-APR-2030 |
View |
| 1715 |
LUCIDEUCRA |
DEUCRAVACITINIB 6 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT WITH MODERATE TO SEVERE PLAQUE PSORIASIS WHO ARE CANDIDATE FOR SYSTEMIC THERAPY OR PHOTOTHERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1111/24 |
21-JUN-2024 |
20 JUN 2027 |
View |
| 1716 |
LUCIELACE |
ELACESTRANT 345 MG |
TABLET |
BOTTLE |
TREATMENT OF POSTMENOPAUSAL WOMEN OR ADULT MEN, WITH ER POSITIVE, HER2 NEGATIVE, ESR1 MUTATED ADVANCED OR METASTATIC BREAT CANCER WITH DISEASE PROGRESSION FOLLOWING AT LEAST ONE LINE OF ENDOCRINE THERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1193/24 |
24-SEP-2024 |
23-SEP-2029 |
View |
| 1717 |
LUCIELACE |
ELACESTRANT 86 MG |
TABLET |
BOTTLE |
TREATMENT OF POSTMENOPAUSAL WOMEN OR ADULT MEN, WITH ER POSITIVE, HER2 NEGATIVE, ESR1 MUTATED ADVANCED OR METASTATIC BREAT CANCER WITH DISEASE PROGRESSION FOLLOWING AT LEAST ONE LINE OF ENDOCRINE THERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1197/24 |
24-SEP-2024 |
23-SEP-2029 |
View |
| 1718 |
LUCIELAFIB |
ELAFIBRANOR 80 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS IN COMBINATION WITH URODEOXYCHOLIC IN ADULTS WHO HAVE AN INADEQUATE RESPONSE TO UDCA OR MONOTHERAPY IN PATIENTS UNABLE TO TOLERATE UDCA |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 1297/25 |
25-FEB-2025 |
24-FEB-2030 |
View |
| 1719 |
LUCIELO 25 |
ELTROMBOPAG 25 MG |
TABLET |
BOTTLE |
TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PAEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE THROMBOCYTOPENIA |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
05 L 0969/23 |
11-MAY-2023 |
10-MAY-2026 |
View |
| 1720 |
LUCIELO 50 |
ELTROMBOPAG 50 MG |
TABLET |
BOTTLE |
TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PAEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE THROMBOCYTOPENIA |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
05 L 0968/23 |
11-MAY-2023 |
10-MAY-2026 |
View |
